Endocrinology, Vol 134, 1127-1131, Copyright © 1994 by Endocrine Society

ARTICLES

Hypothalamic paraventricular nucleus lesions differentially affect serotonin-1A (5-HT1A) and 5-HT2 receptor agonist-induced oxytocin, prolactin, and corticosterone responses

G Bagdy and GB Makara
Laboratory of Experimental Medicine, National Institute of Psychiatry and Neurology, Budapest, Hungary.

A number of receptor subtypes mediate hormonal responses to serotonin (5-HT). To test the hypothesis that the hypothalamic paraventricular nucleus (PVN) mediates 5-HT1A and 5-HT2 receptor-mediated oxytocin, PRL, and corticosterone responses, we studied the effects of the 5-HT1A agonist ipsapirone and the 5-HT2A/2C agonist 1-(2,5-dimethoxy-4- iodophenyl)2-aminopropane (DOI) after surgical PVN lesions or sham operations. Chronically cannulated, conscious, freely moving, male Wistar rats were injected iv (1 mg/kg) shortly after (3-4 days) and 5 weeks after (35-37 days) the operations. In sham-operated rats, ipsapirone caused marked elevations in plasma PRL and corticosterone, but not oxytocin concentrations, whereas DOI increased plasma concentrations of all three hormones. Short term PVN lesions prevented ipsapirone-induced corticosterone and DOI-induced oxytocin responses. DOI-induced PRL and corticosterone responses were also markedly inhibited 3-4 days after lesioning, although small rises over the baseline values were still observed. The ipsapirone-induced PRL response was unaffected by the lesioning. Five weeks after PVN lesioning, partial recoveries were observed in ipsapirone- and DOI- induced corticosterone and DOI-induced oxytocin responses, whereas DOI- induced PRL responses remained suppressed. The present findings suggest that the PVN or neural pathways close to it mediate oxytocin, PRL, and corticosterone responses to the 5-HT2 receptor agonist DOI as well as corticosterone, but not PRL, responses to the 5-HT1A receptor agonist ipsapirone. The results after long term PVN lesioning show that the oxytocin and corticosterone responses may be partially restored with time after lesioning.

This article has been cited by other articles:

				P. Fitzgerald and T. G Dinan Prolactin and dopamine: What is the connection? A Review Article J Psychopharmacol, March 1, 2008; 22(2_suppl): 12 - 19. [Abstract] [PDF]

				P. Osei-Owusu, A. James, J. Crane, and K. E. Scrogin 5-Hydroxytryptamine 1A Receptors in the Paraventricular Nucleus of the Hypothalamus Mediate Oxytocin and Adrenocorticotropin Hormone Release and Some Behavioral Components of the Serotonin Syndrome J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1324 - 1330. [Abstract] [Full Text] [PDF]

				Y. Zhang, K. J. Damjanoska, G. A. Carrasco, B. Dudas, D. N. D'Souza, J. Tetzlaff, F. Garcia, N. R. S. Hanley, K. Scripathirathan, B. R. Petersen, et al. Evidence That 5-HT2A Receptors in the Hypothalamic Paraventricular Nucleus Mediate Neuroendocrine Responses to (-)DOI J. Neurosci., November 1, 2002; 22(21): 9635 - 9642. [Abstract] [Full Text] [PDF]

				A. Roy, N. Mittal, H. Zhang, and S. C. Pandey Modulation of Cellular Expression of Glucocorticoid Receptor and Glucocorticoid Response Element-DNA Binding in Rat Brain during Alcohol Drinking and Withdrawal J. Pharmacol. Exp. Ther., May 1, 2002; 301(2): 774 - 784. [Abstract] [Full Text] [PDF]

				Y. Zhang, D. D'Souza, D. K. Raap, F. Garcia, G. Battaglia, N. A. Muma, and L. D. Van de Kar Characterization of the Functional Heterologous Desensitization of Hypothalamic 5-HT1A Receptors after 5-HT2A Receptor Activation J. Neurosci., October 15, 2001; 21(20): 7919 - 7927. [Abstract] [Full Text] [PDF]

				L. D. Van de Kar, A. Javed, Y. Zhang, F. Serres, D. K. Raap, and T. S. Gray 5-HT2A Receptors Stimulate ACTH, Corticosterone, Oxytocin, Renin, and Prolactin Release and Activate Hypothalamic CRF and Oxytocin-Expressing Cells J. Neurosci., May 15, 2001; 21(10): 3572 - 3579. [Abstract] [Full Text] [PDF]

				M. E. Freeman, B. Kanyicska, A. Lerant, and G. Nagy Prolactin: Structure, Function, and Regulation of Secretion Physiol Rev, October 1, 2000; 80(4): 1523 - 1631. [Abstract] [Full Text] [PDF]

				L. D. V. d. Kar, Q. Li, T. M. Cabrera, M. S. Brownfield, and G. Battaglia Alterations in 8-Hydroxy-2-(dipropylamino)tetralin-Induced Neuroendocrine Responses after 5,7-Dihydroxytryptamine-Induced Denervation of Serotonergic Neurons J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 256 - 262. [Abstract] [Full Text]

				G. BAGDY Serotonin, Anxiety, and Stress Hormones: Focus on 5-HT Receptor Subtypes, Species and Gender Differences Ann. N.Y. Acad. Sci., June 30, 1998; 851(1): 357 - 363. [Full Text] [PDF]

				Q. Li, N. A. Muma, G. Battaglia, and L. D. Van De Kar A Desensitization of Hypothalamic 5-HT1A Receptors by Repeated Injections of Paroxetine: Reduction in the Levels of Gi and Go Proteins and Neuroendocrine Responses, but Not in the Density of 5-HT1A Receptors J. Pharmacol. Exp. Ther., September 1, 1997; 282(3): 1581 - 1590. [Abstract] [Full Text]